aTyr Pharma (NASDAQ:LIFE) Lifted to Hold at StockNews.com

StockNews.com upgraded shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from a sell rating to a hold rating in a research note released on Friday morning. Several other research firms have also commented on LIFE. Piper Sandler lifted their price target on shares of aTyr Pharma from $13.00 to $20.00 and gave the company an […]

Related Keywords

United States ,Paul Schimmel ,Piper Sandler ,Virtu Financial ,Squarepoint Ops ,Charles Schwab Investment Management Inc ,Atyr Pharma Inc ,Vontobel Holding Ltd ,Tyr Pharma ,Free Report ,Moderate Buy ,Tyr Pharma Stock Down ,Get Free Report ,Director Paul Schimmel ,Street Group ,Schwab Investment Management ,Tyr Pharma Daily ,Atyr Pharma ,Nasdaq Life ,Life ,Medical ,53217v10 ,Upgrade ,Stocknews Com ,